about
HEF1 promotes epithelial mesenchymal transition and bone invasion in prostate cancer under the regulation of microRNA-145Wild-type p53 suppresses the epithelial-mesenchymal transition and stemness in PC-3 prostate cancer cells by modulating miR‑145.Thymosin beta 10 is a key regulator of tumorigenesis and metastasis and a novel serum marker in breast cancer.miR‑150 inhibits proliferation and tumorigenicity via retarding G1/S phase transition in nasopharyngeal carcinoma.Acidic extracellular pH promotes prostate cancer bone metastasis by enhancing PC-3 stem cell characteristics, cell invasiveness and VEGF-induced vasculogenesis of BM-EPCs.N-cadherin promotes epithelial-mesenchymal transition and cancer stem cell-like traits via ErbB signaling in prostate cancer cells.Double-negative feedback loop between ZEB2 and miR-145 regulates epithelial-mesenchymal transition and stem cell properties in prostate cancer cells.Loss of miR-100 enhances migration, invasion, epithelial-mesenchymal transition and stemness properties in prostate cancer cells through targeting Argonaute 2.Oncogenic miR-210-3p promotes prostate cancer cell EMT and bone metastasis via NF-κB signaling pathway.Maintenance of cancer stemness by miR-196b-5p contributes to chemoresistance of colorectal cancer cells via activating STAT3 signaling pathwayPhospholipid Phosphatase 4 promotes proliferation and tumorigenesis, and activates Ca2+-permeable Cationic Channel in lung carcinoma cells.Downregulation of miR-141-3p promotes bone metastasis via activating NF-κB signaling in prostate cancer.RCC2 over-expression in tumor cells alters apoptosis and drug sensitivity by regulating Rac1 activation.Downregulation of miR‑19a‑3p promotes invasion, migration and bone metastasis via activating TGF‑β signaling in prostate cancer.TFAP2C promotes stemness and chemotherapeutic resistance in colorectal cancer via inactivating hippo signaling pathway.miR-217 targeting DKK1 promotes cancer stem cell properties via activation of the Wnt signaling pathway in hepatocellular carcinoma.The TGF-β signalling negative regulator PICK1 represses prostate cancer metastasis to bone.miR-1266 Contributes to Pancreatic Cancer Progression and Chemoresistance by the STAT3 and NF-κB Signaling Pathways.
P50
Q28284329-7767FEE9-0B30-49D9-ACB0-12CB7235B0A8Q34327507-21177DA1-732B-4504-B51F-96A277A3A199Q37633634-B220C054-23DF-4AE4-907E-947636CF5A72Q37718685-64C5D919-D8C6-437C-987A-C573C26CC2C4Q38753317-82DB1DFC-0F50-485C-8FEB-A24DCE11F6CAQ38813408-CEE2DE88-3C87-4332-A4AD-51286221AA15Q38949698-0D0BC170-23E3-4776-B82A-4719DA615869Q38997490-8B160374-C642-4861-A924-30366B313BF1Q40977712-F8004766-E4D4-4530-B201-C4546DD0914FQ41472760-6E6E220A-2B05-420C-94EC-67B967C20C21Q41558346-DFAC24DF-384E-406D-9143-6E065C1CF6C0Q47146670-4EA007A9-6A83-417B-B460-AAE9DF3C670CQ49366921-87B24333-4249-476E-9712-DF3403AFE129Q49461890-2D1EAD3D-0675-4AD0-8C82-9F92175AFB4EQ49802266-496CFD8C-DAE2-4E99-9CB0-4C2E5404A90FQ50494005-7ACECBEA-B8ED-4CD1-973F-9183C3456E80Q50897114-5850664C-7938-4057-BF21-2AA80AEC4BD5Q55368106-F5F3CFB3-600D-4EB2-992D-C487CEA54163
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Dong Ren
@ast
Dong Ren
@en
Dong Ren
@es
Dong Ren
@nl
Dong Ren
@sl
type
label
Dong Ren
@ast
Dong Ren
@en
Dong Ren
@es
Dong Ren
@nl
Dong Ren
@sl
prefLabel
Dong Ren
@ast
Dong Ren
@en
Dong Ren
@es
Dong Ren
@nl
Dong Ren
@sl
P106
P31
P496
0000-0002-0843-0246